luckyspinfree| Australia bans pharmacies from producing generic versions of "weight-loss drugs"

Australia will ban pharmacies from producing replicas of popular weight-loss drugs such as OzempicluckyspinfreeThere have been previous reports that these drugs have dangerous side effects, including the hospitalization of a patient due to a "serious adverse event."

Australia Health Minister Mark Butler said in a statement on Wednesday that pharmacies will be restricted to producing compound GLP-1 receptor agonist products-a class of drugs that help control blood sugar levels-for individual patients. The loophole previously allowed the production of products similar to Ozempic that had not been approved by Australia regulators.

According to Butler, more than 20,000 Australia patients have been using such generic drugs, mainly forluckyspinfreeto lose weight.

A surge in demand for weight-loss drugs, including Novo Nordisk's Ozempic, has led to a global shortage of such drugs, although some users have reported side effects including nausea. A poll of U.S. consumers conducted in May found that one in eight had tried various variants of this new drug.

The Australia government's move is supported by the country's Medicines Administration, and internationally, the U.S. Food and Drug Administration (FDA) has warned of the dangers of injecting some compound products after adverse events in the United States.